Gastric Cancer Surgery During the Pandemic: What It Costs?
COVID
Cancer
Gastric
Pathology
Journal
Journal of gastrointestinal cancer
ISSN: 1941-6636
Titre abrégé: J Gastrointest Cancer
Pays: United States
ID NLM: 101479627
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
accepted:
29
10
2021
pubmed:
24
11
2021
medline:
5
11
2022
entrez:
23
11
2021
Statut:
ppublish
Résumé
From the early days of 2020, the COVID-19 pandemic continues to change whole life all around the world. Oncological patients are the most affected populations since these days. Because of decreasing numbers in surgery and endoscopy, gastric cancer patients had difficulties in treatment and diagnoses. Therefore, the early and long-term results may be affected during the pandemic. In this study, we aimed to evaluate pandemia effects on gastric cancer surgery in a single center. Patients were categorized as the COVID group and the Pre-COVID group. Patients who received neoadjuvant chemotherapy were excluded from the study. In the COVID period, 50 patients underwent gastric cancer surgery, while 64 were operated on in the pre-COVID period. Patients' demographics and clinical and pathological outcomes were evaluated. There was no statistically significant difference in both periods among patient characteristics such as age, gender, and body mass index. Pre-operative laboratory results were similar between two groups. Although there was no difference in operation types, an increase was detected in Clavien-Dindo grade 3 and higher complications during the COVID period. During the pandemic, there was a significant difference in the pathological outcomes. Peritoneal cytology-positive patients were hıgher in the COVID group. More lymphovascular invasions were also detected in the COVID period. Finally, it resulted stage differences between two groups. Because of COVID-19's heavy burden on healthcare system, delays in the diagnosis and treatment of oncological patients may occur. Therefore, this may be affected pathological and survival outcomes of cancer patients. Finally, further investigations are needed.
Sections du résumé
BACKGROUND
BACKGROUND
From the early days of 2020, the COVID-19 pandemic continues to change whole life all around the world. Oncological patients are the most affected populations since these days. Because of decreasing numbers in surgery and endoscopy, gastric cancer patients had difficulties in treatment and diagnoses. Therefore, the early and long-term results may be affected during the pandemic. In this study, we aimed to evaluate pandemia effects on gastric cancer surgery in a single center.
PATIENTS-METHODS
METHODS
Patients were categorized as the COVID group and the Pre-COVID group. Patients who received neoadjuvant chemotherapy were excluded from the study. In the COVID period, 50 patients underwent gastric cancer surgery, while 64 were operated on in the pre-COVID period. Patients' demographics and clinical and pathological outcomes were evaluated.
RESULTS
RESULTS
There was no statistically significant difference in both periods among patient characteristics such as age, gender, and body mass index. Pre-operative laboratory results were similar between two groups. Although there was no difference in operation types, an increase was detected in Clavien-Dindo grade 3 and higher complications during the COVID period. During the pandemic, there was a significant difference in the pathological outcomes. Peritoneal cytology-positive patients were hıgher in the COVID group. More lymphovascular invasions were also detected in the COVID period. Finally, it resulted stage differences between two groups.
CONCLUSION
CONCLUSIONS
Because of COVID-19's heavy burden on healthcare system, delays in the diagnosis and treatment of oncological patients may occur. Therefore, this may be affected pathological and survival outcomes of cancer patients. Finally, further investigations are needed.
Identifiants
pubmed: 34811648
doi: 10.1007/s12029-021-00751-6
pii: 10.1007/s12029-021-00751-6
pmc: PMC8608237
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
848-853Informations de copyright
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.
Références
Cinar P, Kubal T, Freifeld A, Mishra A, Shulman L, Bachman J, et al. Safety at the time of the COVID-19 pandemic: how to keep our oncology patients and healthcare workers safe. JNCCN J Natl Compr Cancer Netw. 2020;18:504–9.
doi: 10.6004/jnccn.2020.7572
Torzilli G, Viganò L, Galvanin J, Castoro C, Quagliuolo V, Spinelli A, et al. A snapshot of elective oncological surgery in Italy during COVID-19 emergency: pearls, pitfalls, and perspectives. Ann Surg. 2020;272:e112–7.
doi: 10.1097/SLA.0000000000004081
pubmed: 32675512
Rutter MD, Brookes M, Lee TJ, Rogers P, Sharp L. Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a national endoscopy database analysis. Gut. 2021;70:537–43.
doi: 10.1136/gutjnl-2020-322179
pubmed: 32690602
Bhat PKR, Santosh Kumar K Y, Sorake C, Kulamarva G. Gastrointestinal malignancies and the COVID-19 pandemic: evidence-based triage to surgery. J Gastrointest Surg. 2020;24:2698–9.
Li YX, He CZ, Liu YC, Zhao PY, Xu XL, Wang YF, et al. The impact of COVID-19 on gastric cancer surgery: a single-center retrospective study. BMC Surg BMC Surgery. 2020;20:1–7.
pubmed: 31898499
Pinato DJ, Zambelli A, Bertuzzi A, Marrari A, Saoudi-Gonzalez N, Mirallas O, et al. 318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. Ann Oncol [Internet]. Elsevier Ltd.; 2020;31:S1366. Available from: https://doi.org/10.1016/j.annonc.2020.10.312
Parasa S, Reddy N, Faigel DO, Repici A, Emura F, Sharma P. Global impact of the COVID-19 pandemic on endoscopy: an international survey of 252 centers from 55 countries. Gastroenterology [Internet] 2020;159:1579–1581.e5. The American Gastroenterological Association. Available from. https://doi.org/10.1053/j.gastro.2020.06.009
Crawford SC, Davis JA, Siddiqui NA, De Caestecker L, Gillis CR, Hole D. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. Br Med J. 2002;325:196.
doi: 10.1136/bmj.325.7357.196
Furukawa K, Irino T, Makuuchi R, Koseki Y, Nakamura K, Waki Y, et al. Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer. Gastric Cancer [Internet] 2019;22:864–72. Springer Japan. Available from. https://doi.org/10.1007/s10120-018-00910-y
Brenkman HJF, Visser E, van Rossum PSN, Siesling S, van Hillegersberg R, Ruurda JP. Association between waiting time from diagnosis to treatment and survival in patients with curable gastric cancer: a population-based study in the Netherlands. Ann Surg Oncol. 2017;24:1761–9.
doi: 10.1245/s10434-017-5820-8
pubmed: 28353020
pmcid: 5486840
Yun YH, Kim YA, Min YH, Park S, Won YJ, Kim DY, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol. 2012;23:2731–7.
doi: 10.1093/annonc/mds101
pubmed: 22553194
Shin DW, Cho J, Kim SY, Guallar E, Hwang SS, Cho B, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013;20:2468–76.
doi: 10.1245/s10434-013-2957-y
pubmed: 23529782